FDA approves Sandoz drug for fungal infections
PRINCETON, N.J. — The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.
Sandoz announced Monday the approval of voriconazole tablets in the 50-mg and 200-mg strengths, a generic version of Pfizer's Vfend.
Branded and generic versions of the drug had sales of about $189 million during the 12-month period ended in October, according to IMS Health.
Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.